查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1803052

全球人工智慧驱动的慢性疼痛管理市场预测（至 2032 年）：按组件、部署类型、分销管道、应用、最终用户和地区进行分析

AI Chronic Pain Management Market Forecasts to 2032 - Global Analysis By Component (Software, Hardware, and Services), Deployment Mode, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球 AI 慢性疼痛管理市场预计在 2025 年达到 60.7 亿美元，到 2032 年将达到 207.8 亿美元，预测期内的复合年增长率为 19.2%。

AI慢性疼痛管理是指应用人工智慧技术来评估、监测和治疗长期疼痛状况。它整合了机器学习、预测分析和数位工具，以个人化疼痛管理策略，提高诊断准确性并优化治疗效果。透过分析患者数据、穿戴式装置输入和病历，AI可以实现早期疗育，减少阿片类药物依赖，并改善慢性疼痛患者的整体生活品质。

慢性疼痛的流行

全球慢性疼痛的增加推动了对创新疼痛管理解决方案的需求。由于人口老化和生活方式因素，关节炎、纤维肌痛和神经病变疼痛等疾病正变得越来越普遍。传统的疼痛管理方法往往无法提供长期缓解，这激发了人们对人工智慧方法的兴趣。人工智慧技术能够更精确地分析患者数据并优化治疗方案。随着医疗保健系统寻求更有效、更具可扩展性的解决方案，人工智慧正逐渐成为个人化疼痛照护的关键推动因素。这种日益增长的需求正在推动医院、诊所和数位健康平台的投资和应用。

来自医疗保健专业人士的抵制

对数据可靠性、临床检验以及缺乏人工监督的担忧阻碍了人工智慧的推广应用。医生可能不愿意相信演算法推荐，而更倾向于相信自己的临床判断，尤其是在复杂的疼痛病例中。有限的培训和人工智慧工具的机会进一步加剧了医学界的阻力。此外，监管的不确定性和伦理方面的考虑也导致人们对采用基于人工智慧的干预措施犹豫不决。这种阻力减缓了市场渗透，并限制了人工智慧在疼痛治疗领域中变革的潜力。

个人化预测护理

预测演算法可以透过预测疼痛发作并建议预防性干预措施来改善患者的治疗效果。这些功能支持主动护理模式，减少对被动且通常无效的治疗的依赖。与穿戴式装置和行动应用程式的整合增强了即时监控和回馈迴路。随着精准医疗的日益普及，人工智慧驱动的疼痛管理与个人化医疗的整体医疗趋势相契合。这一机会正吸引新兴企业、科技巨头和差异化医疗服务提供者。

预测不准确和病人受伤的风险

疼痛管理中的人工智慧系统容易受到资料集偏差或不完整导致的误差的影响。误诊和不恰当的治疗建议可能会对患者造成伤害，并削弱人们对该技术的信任。过度依赖缺乏适当临床监督的演算法可能会加剧风险，尤其是在复杂或非典型病例中。预测模型中的错误可能导致治疗延误并使患者病情恶化。监管审查正在加强，以确保人工智慧应用的安全性和课责。这些风险对市场信誉和长期应用构成了重大威胁。

COVID-19的影响

新冠疫情加速了数位医疗工具（包括基于人工智慧的疼痛管理平台）的普及。封锁措施和麵对面诊疗服务受限，增加了对远端监控和虚拟咨询的需求。人工智慧工具透过实现症状追踪和居家治疗协调，填补了慢性疼痛护理领域的空白。然而，供应链中断和资本重新配置暂时减缓了新型人工智慧解决方案的开发和部署。这种转变将继续支持人工智慧主导的慢性疼痛管理解决方案的成长。

预计软体领域将成为预测期内最大的领域

由于个人化治疗工具、用于疼痛预测的先进机器学习以及云端远距远端医疗解决方案的日益普及，预计软体领域将在预测期内占据最大的市场占有率。值得关注的趋势包括基于应用程式的疼痛监测、与穿戴式装置的整合以及基于订阅的人工智慧平台。近期的进展体现在科技公司与医疗保健提供者之间的合作，旨在建立可互通的系统，以支援与电子健康记录的一致性、简化临床决策流程以及以患者为中心、以结果主导的护理模式。

预计居家医疗领域在预测期内将以最高复合年增长率成长

预计居家医疗领域将在预测期内实现最高增长率，这得益于人们对物联网设备、可穿戴感测器和基于人工智慧的监控系统等技术支援的远端个人化护理的兴趣日益浓厚。主要趋势包括虚拟疼痛管理、即时数据驱动的自适应护理以及用于早期症状检测的预测工具。近期的创新促使技术提供者和医疗保健机构建立策略合作伙伴关係，提供扩充性的云端支援平台，以增强患者能力，减少对医院的依赖，并与不断发展的报销和基于价值的护理模式保持一致。

占比最大的地区：

由于慢性疼痛患者数量的增加、数位医疗系统的扩展以及向非阿片类药物治疗的转变，预计亚太地区将在预测期内占据最大的市场占有率。人工智慧整合行动平台、穿戴式健康追踪器和云端基础的分析等技术正日益普及。主要趋势包括虚拟疼痛支援、多语言人工智慧工具和远端医疗整合。近期发展包括区域高科技医疗伙伴关係、政府主导的数位医疗项目，以及对可扩展人工智慧解决方案的投资增加，以满足多样化的患者需求。

复合年增长率最高的地区：

由于慢性疼痛患者人数众多、医疗保健体系健全以及数位化治疗解决方案的广泛应用，北美预计将在预测期内呈现最高的复合年增长率。人工智慧诊断工具、穿戴式疼痛监测设备以及与电子健康记录相连的云端整合平台等技术是关键推动因素。新兴趋势包括个人化疼痛管理演算法、神经调节洞察和虚拟指导。近期的里程碑包括医院采用人工智慧工具的激增、生技药品研究资金的增加以及基于远端医疗的疼痛护理服务的扩展。

提供免费客製化：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究资讯来源
    • 初级研究资讯来源
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球人工智慧慢性疼痛管理市场（按组成部分）

  • 软体
  • 硬体
  • 服务

6. 全球人工智慧慢性疼痛管理市场（按部署类型）

  • 云端基础
  • 本地

7. 全球人工智慧慢性疼痛管理市场（按分销管道）

  • 线上平台
  • 离线

8. 全球人工智慧慢性疼痛管理市场（按应用）

  • 神经病变疼痛
  • 肌肉骨骼疼痛
  • 癌症相关疼痛
  • 偏头痛和脸部疼痛
  • 纤维肌痛
  • 其他用途

9. 全球人工智慧慢性疼痛管理市场（按最终用户）

  • 医院和诊所
  • 居家医疗
  • 门诊手术中心
  • 研究所
  • 学术中心
  • 护理设施
  • 其他最终用户

10. 全球人工智慧慢性疼痛管理市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章：企业概况

  • Johnson & Johnson
  • Horizon Therapeutics
  • Pfizer
  • Amgen
  • Medtronic
  • Mallinckrodt
  • Teva Pharmaceuticals
  • AstraZeneca
  • AbbVie
  • Bristol-Myers Squibb
  • Eli Lilly
  • Regeneron Pharmaceuticals
  • Boehringer Ingelheim
  • Novartis
  • GlaxoSmithKline（GSK）
Product Code: SMRC30577

According to Stratistics MRC, the Global AI Chronic Pain Management Market is accounted for $6.07 billion in 2025 and is expected to reach $20.78 billion by 2032 growing at a CAGR of 19.2% during the forecast period. AI Chronic Pain Management refers to the application of artificial intelligence technologies to assess, monitor, and treat long-term pain conditions. It integrates machine learning, predictive analytics, and digital tools to personalize pain management strategies, improve diagnosis accuracy, and optimize treatment outcomes. By analyzing patient data, wearable device inputs, and medical histories, AI enables early intervention, reduces dependency on opioids, and enhances overall quality of life for individuals suffering from chronic pain.

Market Dynamics:

Driver:

Growing prevalence of chronic pain

The increasing global burden of chronic pain is driving demand for innovative management solutions. Conditions such as arthritis, fibromyalgia, and neuropathic pain are becoming more prevalent due to aging populations and lifestyle factors. Traditional pain management methods often fall short in providing long-term relief, prompting interest in AI-driven approaches. AI technologies offer the potential to analyse patient data and optimize treatment plans with greater precision. As healthcare systems seek more effective and scalable solutions, AI is emerging as a key enabler of personalized pain care. This growing need is catalysing investments and adoption across hospitals, clinics, and digital health platforms.

Restraint:

Resistance from healthcare professionals

Concerns around data reliability, clinical validation, and loss of human oversight hinder adoption. Physicians may be reluctant to trust algorithmic recommendations over their clinical judgment, especially in complex pain cases. Limited training and exposure to AI tools further exacerbate resistance within the medical community. Additionally, regulatory ambiguity and ethical considerations contribute to hesitation in deploying AI-based interventions. This resistance slows market penetration and limits the full potential of AI in transforming pain care.

Opportunity:

Personalized and predictive treatment

Predictive algorithms can forecast pain flare-ups and recommend pre-emptive interventions, improving patient outcomes. These capabilities support proactive care models, reducing reliance on reactive and often ineffective treatments. Integration with wearable devices and mobile apps enhances real-time monitoring and feedback loops. As precision medicine gains traction, AI-driven pain management aligns with broader healthcare trends toward individualized care. This opportunity is attracting start-ups, tech giants, and healthcare providers seeking to differentiate their offerings.

Threat:

Risk of inaccurate predictions and patient harm

AI systems in pain management are vulnerable to inaccuracies stemming from biased or incomplete datasets. Misdiagnosis or inappropriate treatment recommendations can lead to patient harm, undermining trust in the technology. Overreliance on algorithms without adequate clinical oversight may exacerbate risks, especially in complex or atypical cases. Errors in prediction models can result in delayed care, worsening patient conditions. Regulatory scrutiny is intensifying to ensure safety and accountability in AI applications. These risks pose a significant threat to market credibility and long-term adoption.

Covid-19 Impact

The COVID-19 pandemic accelerated the adoption of digital health tools, including AI-based pain management platforms. Lockdowns and limited access to in-person care drove demand for remote monitoring and virtual consultations. AI tools helped bridge gaps in chronic pain care by enabling symptom tracking and treatment adjustments from home. However, supply chain disruptions and funding reallocations temporarily slowed development and deployment of new AI solutions. This shift continues to support growth in AI-driven chronic pain management solutions.

The softwaresegment is expected to be the largest during the forecast period

The softwaresegment is expected to account for the largest market share during the forecast period, fuelled by increasing adoption of personalized treatment tools, advanced machine learning for pain prediction, and cloud-enabled remote care solutions. Notable trends include app-based pain monitoring, integration with wearable devices, and subscription-based AI platforms. Recent advancements feature collaborations between tech companies and healthcare providers to create interoperable systems that align with electronic health records, streamline clinical decision-making, and support patient-centric, outcome-driven care models.

The homecaresegment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecaresegment is predicted to witness the highest growth rate, driven by growing interest in remote, individualized care supported by technologies like IoT-enabled devices, wearable sensors, and AI-based monitoring systems. Key trends include virtual pain management, real-time data-driven adaptive care, and predictive tools for early symptom detection. Recent innovations involve strategic alliances between technology providers and healthcare organizations to deliver scalable, cloud-supported platforms that empower patients, lower hospital dependency, and align with evolving reimbursement and value-based care models.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market sharedue to increasing cases of chronic pain, expanding digital healthcare systems, and a shift toward non-opioid treatment options. Technologies such as AI-integrated mobile platforms, wearable health trackers, and cloud-based analytics are gaining traction. Key trends include virtual pain support, multilingual AI tools, and telemedicine integration. Recent progress includes regional tech-healthcare partnerships, government-led digital health programs, and rising investments in scalable AI solutions tailored to diverse patient needs.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to widespread chronic pain cases, robust healthcare systems, and strong uptake of digital treatment solutions. Technologies such as AI-driven diagnostic tools, wearable pain monitoring devices, and cloud-integrated platforms linked to electronic health records are key enablers. Emerging trends include personalized pain management algorithms, neuromodulation insights, and virtual coaching. Recent milestones include a surge in hospital adoption of AI tools, increased funding for biologics research, and expanded telehealth-based pain care services.

Key players in the market

Some of the key players profiled in the AI Chronic Pain Management Market includeJohnson & Johnson, Horizon Therapeutics, Pfizer, Amgen, Medtronic, Mallinckrodt, Teva Pharmaceuticals, AstraZeneca, AbbVie, Bristol-Myers Squibb, Eli Lilly, Regeneron Pharmaceuticals, BoehringerIngelheim, Novartis, and GlaxoSmithKline (GSK).

Key Developments:

In July2025, Johnson & Johnson announced the launch of the VIRTUGUIDE(TM) System. This AI-powered, patient-matched solution is designed to support Lapidus procedures2, a type of bunion surgery that helps realign the foot by joining two bones near the arch (the first metatarsal bone and the medial cuneiform).3 The system uses pre-operative planning software, developed in collaboration with PeekMed(R), to assess each patient's bunion and make personalized recommendations for the intended correction.

In October2023,Amgen announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.

Components Covered:

  • Software
  • Hardware
  • Services

Deployment Modes Covered:

  • Cloud-Based
  • On-Premises

Distribution Channels Covered:

  • Online Platforms
  • Offline

Applications Covered:

  • Neuropathic Pain
  • Musculoskeletal Pain
  • Cancer-related Pain
  • Migraine and Facial Pain
  • Fibromyalgia
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Homecare
  • Ambulatory Surgical Centers
  • Research Institutions
  • Academic Centers
  • Nursing Homes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global AI Chronic Pain Management Market, By Component

  • 5.1 Introduction
  • 5.2 Software
  • 5.3 Hardware
  • 5.4 Services

6 Global AI Chronic Pain Management Market, By Deployment Mode

  • 6.1 Introduction
  • 6.2 Cloud-Based
  • 6.3 On-Premises

7 Global AI Chronic Pain Management Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Platforms
  • 7.3 Offline

8 Global AI Chronic Pain Management Market, By Application

  • 8.1 Introduction
  • 8.2 Neuropathic Pain
  • 8.3 Musculoskeletal Pain
  • 8.4 Cancer-related Pain
  • 8.5 Migraine and Facial Pain
  • 8.6 Fibromyalgia
  • 8.7 Other Applications

9 Global AI Chronic Pain Management Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Clinics
  • 9.3 Homecare
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Research Institutions
  • 9.6 Academic Centers
  • 9.7 Nursing Homes
  • 9.8 Other End Users

10 Global AI Chronic Pain Management Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Horizon Therapeutics
  • 12.3 Pfizer
  • 12.4 Amgen
  • 12.5 Medtronic
  • 12.6 Mallinckrodt
  • 12.7 Teva Pharmaceuticals
  • 12.8 AstraZeneca
  • 12.9 AbbVie
  • 12.10 Bristol-Myers Squibb
  • 12.11 Eli Lilly
  • 12.12 Regeneron Pharmaceuticals
  • 12.13 Boehringer Ingelheim
  • 12.14 Novartis
  • 12.15 GlaxoSmithKline (GSK)

List of Tables

  • Table 1 Global AI Chronic Pain Management Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 4 Global AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 5 Global AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 6 Global AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 7 Global AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 8 Global AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 9 Global AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 10 Global AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 11 Global AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 12 Global AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 14 Global AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 15 Global AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 16 Global AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 17 Global AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 18 Global AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 19 Global AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 21 Global AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 22 Global AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 23 Global AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 24 Global AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 25 Global AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 26 Global AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 27 North America AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 28 North America AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 29 North America AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 30 North America AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 31 North America AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 32 North America AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 33 North America AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 34 North America AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 35 North America AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 36 North America AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 37 North America AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 38 North America AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 39 North America AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 40 North America AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 41 North America AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 42 North America AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 43 North America AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 44 North America AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 45 North America AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 46 North America AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 47 North America AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 48 North America AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 49 North America AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 50 North America AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 51 North America AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 52 North America AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 53 Europe AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 54 Europe AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 55 Europe AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 56 Europe AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 57 Europe AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 58 Europe AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 59 Europe AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 60 Europe AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 61 Europe AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 62 Europe AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 63 Europe AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 64 Europe AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 65 Europe AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 66 Europe AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 67 Europe AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 68 Europe AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 69 Europe AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 70 Europe AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 71 Europe AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 72 Europe AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 73 Europe AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 74 Europe AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 75 Europe AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 76 Europe AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 77 Europe AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 78 Europe AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 79 Asia Pacific AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 80 Asia Pacific AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 81 Asia Pacific AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 82 Asia Pacific AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 83 Asia Pacific AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 84 Asia Pacific AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 85 Asia Pacific AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 86 Asia Pacific AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 87 Asia Pacific AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 88 Asia Pacific AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 89 Asia Pacific AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 90 Asia Pacific AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 91 Asia Pacific AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 92 Asia Pacific AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 93 Asia Pacific AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 94 Asia Pacific AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 95 Asia Pacific AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 96 Asia Pacific AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 97 Asia Pacific AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 98 Asia Pacific AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 99 Asia Pacific AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 100 Asia Pacific AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 101 Asia Pacific AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 102 Asia Pacific AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 103 Asia Pacific AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 104 Asia Pacific AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 105 South America AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 106 South America AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 107 South America AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 108 South America AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 109 South America AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 110 South America AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 111 South America AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 112 South America AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 113 South America AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 114 South America AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 115 South America AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 116 South America AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 117 South America AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 118 South America AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 119 South America AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 120 South America AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 121 South America AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 122 South America AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 123 South America AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 124 South America AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 125 South America AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 126 South America AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 127 South America AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 128 South America AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 129 South America AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 130 South America AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 131 Middle East & Africa AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 132 Middle East & Africa AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 133 Middle East & Africa AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 134 Middle East & Africa AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 135 Middle East & Africa AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 136 Middle East & Africa AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 137 Middle East & Africa AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 138 Middle East & Africa AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 139 Middle East & Africa AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 140 Middle East & Africa AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 141 Middle East & Africa AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 142 Middle East & Africa AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 143 Middle East & Africa AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 144 Middle East & Africa AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 145 Middle East & Africa AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 146 Middle East & Africa AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 147 Middle East & Africa AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 148 Middle East & Africa AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 149 Middle East & Africa AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 150 Middle East & Africa AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 151 Middle East & Africa AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 152 Middle East & Africa AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 153 Middle East & Africa AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 154 Middle East & Africa AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 155 Middle East & Africa AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 156 Middle East & Africa AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)